Medical Oncology

Chemotherapy is often recommended following surgical removal of a pancreatic tumor to prevent the disease from returning or to delay its return. Chemotherapy is also prescribed to treat patients with advanced or metastatic disease. Yale Cancer Center Gastrointestinal Oncology Program provides experience and knowledge of innovative treatment options and investigational therapies for pancreatic cancer.

Yale Cancer Center is a major national research center for the development of novel therapies for late stage pancreatic cancer and provides our patients with access to the newest therapies available. Our medical oncologists are also searching for novel combinations of chemotherapy and targeted therapies to further improve the treatment of pancreatic cancer.

Radiation Oncology

Radiation therapy is often used to treat patients who are not eligible for surgery or to shrink the pancreatic tumor prior to surgery in combination with chemotherapy. Three-dimensional conformal radiation delivery techniques and four-dimensional CT simulation are used to decrease toxicity while improving tumor targeting. Stereotactic body radiotherapy is also available. Patients who are cared for through the Yale Cancer Center Gastrointestinal Cancers Program and need radiation oncology as a component of their prescribed treatment can feel confident that they are receiving the highest quality care from the most experienced team of radiation oncologists in Connecticut.

Animation - Pancreatic Cancer - Understanding Clinical Trials

Animation - Pancreatic Cancer - Understanding Clinical Trials

This animation explains what clinical trials are, how they are conducted, and why they are important for patients with diseases like pancreatic cancer. The animation also provides an overview of study design, eligibility criteria, informed consent, safeguards, different phases of clinical trials, and the potential benefits and potential risks of participation.